Reddit is where patients go at 2 a.m. when scared. I monitor dozens of communities for clinically meaningful posts: dangerous myths, gaps between belief and evidence, stories guidelines cannot capture. This series -- ObGyn Intelligence on Reddit -- dissects them against the literature, because ObGyns who ignore social media ignore the most unfiltered window into what patients think, fear, and do between appointments.

Summary

A first-time mother at 9 weeks and 6 days went for her first ultrasound expecting routine news. Instead, she left with three diagnoses in one visit: a bicornuate uterus, vanishing twin syndrome, and a subchorionic hematoma. She turned to Reddit for support and got it -- over 87 comments, mostly from people who had been through the same thing and delivered healthy babies. The community rallied around her with reassurance, personal stories, and a few important clinical warnings. The top comment had 526 upvotes. Her post got more than 1,300. This was not a rare anxiety spiral. It was a community filling a gap that the exam room left open.

The rest of this post is for paid subscribers.

Read more

Twin pregnancy means two fetuses share one uterus. Clinically, that sounds simple. Medically, it is one of the most complex situations in obstetrics. The key fact many patients never hear early enough is this: twin risk is not determined by the number of babies. It is determined by how the placenta is shared.

The first steps after twins are diagnosed is to determine the “chorionicity”.

Obstetricians therefore do not begin twin care by counting fetuses. We begin by identifying chorionicity, meaning how many placentas and how many amniotic sacs exist.

This is ideally determined by ultrasound at 11 to 14 weeks, because later the membranes become harder to interpret.

There are three biologic types of twins.

Dichorionic–diamniotic (di-di).
Each fetus has its own placenta and its own amniotic sac. This includes almost all fraternal twins and about one third of identical twins. The fetuses are physiologically separate. The risks are mainly those of uterine over-distention: preterm birth, maternal hypertension, and growth differences. These are the lowest-risk twins.

Monochorionic–diamniotic (mono-di).
The twins share one placenta but have separate sacs. This occurs when an embryo splits slightly later. Because the placenta is shared, blood vessels connect the twins. That single feature changes everything. One twin can transfuse blood to the other. This produces twin-to-twin transfusion syndrome, growth restriction of one twin, or sudden deterioration of both.

Monochorionic–monoamniotic (mono-mono).
The rarest form. One placenta and one sac. There is no separating membrane. The umbilical cords can entangle and compress. These pregnancies are uncommon but among the highest risk in modern obstetrics.

Coinjoined twins are part of MonoMono twins and are jopined anywhere on their bodies.

Monitoring follows directly from biology.

For di-di twins, surveillance resembles intensified singleton care.
• Anatomy scan at 18–22 weeks
• Growth ultrasound about every 4 weeks beginning at ~24 weeks
• Third-trimester antenatal testing around 32–34 weeks
• Delivery usually at 38 weeks if uncomplicated

For mono-di twins, the placenta requires active surveillance.
• Ultrasound every 2 weeks starting at 16 weeks
• At each visit: amniotic fluid in each sac and bladder filling
• Doppler assessment when concerns arise
The purpose is early detection of twin-to-twin transfusion syndrome and selective growth restriction. If TTTS develops, fetoscopic laser treatment may be needed. Delivery typically occurs around 36–37 weeks.

For mono-mono twins, monitoring becomes preventive rather than reactive.
• Ultrasound every 1–2 weeks in mid-pregnancy
• Intensive fetal surveillance in the third trimester
• Many centers hospitalize around 26–28 weeks for daily monitoring
The reason is cord entanglement, which cannot be predicted by growth scans. Planned cesarean delivery is usually recommended around 32–34 weeks before sudden cord compression occurs.

One important counseling point: twin monitoring is not about doing more ultrasounds for reassurance. It is about watching for specific pathophysiology unique to each placental type. A mono-di pregnancy can look normal one week and show early transfusion syndrome two weeks later. A mono-mono pregnancy can have normal growth and still face acute cord compromise. The schedule is designed around the biology of those risks.

Twin pregnancy therefore requires an early question at the first ultrasound:
not “Are both babies healthy?” but

“How many placentas are there?”

Once that is answered, the rest of prenatal care follows logically. The monitoring plan, visit frequency, and delivery timing are not arbitrary. They are a direct response to how the fetuses share circulation inside the uterus.

A woman has preeclampsia. She delivers. Her baby goes to the NICU. She goes home two days later with a blood pressure cuff and instructions to follow up in six weeks.

She does. Her blood pressure is better. Her doctor says she looks great. She moves on.

Ten years later, she is tired all the time. Her ankles swell. Her doctor orders labs. Her kidney function is seriously impaired.

Nobody made a mistake. Nobody missed an obvious sign. The system did exactly what it was designed to do. That is the problem.

The Connection We Are Not Making

Preeclampsia, preterm birth, and delivering a baby that is small for gestational age are not just pregnancy complications. They are warning signals for what comes next, specifically, for the kidneys.

Chronic kidney disease (CKD) can develop silently, over years, with no symptoms until it is advanced. Pregnancy complications are among its most powerful predictors. And almost no one is connecting these dots at the postpartum visit.

Women with preeclampsia face a 5-fold greater risk of end-stage renal disease, the point at which the kidneys fail and dialysis or transplant becomes necessary. If that preeclampsia was preterm, the risk rises to 9-fold.

CKD is the 9th leading cause of death in women. It disproportionately affects women. And it is almost entirely absent from postpartum care guidelines.

The Guidelines Know. The Clinics Do Not.

The 2024 KDIGO guidelines, from the leading international nephrology organization, explicitly list preeclampsia as a high-risk condition requiring CKD screening. Nephrology societies have made this clear.

ACOG and primary care guidelines focus postpartum follow-up on blood pressure, lipids, and glucose. Kidney function is not there.

The result is a gap between what nephrology recommends and what obstetrics delivers. And women fall through it.

What the Numbers Show

In a Swedish cohort study of more than 170,000 pregnancies, only 20% of women with preeclampsia had kidney function tested in their first postpartum year. Only 10% had urine albumin tested, the most sensitive early marker of kidney damage.

In the Geisinger Health Study, only 31% of women had kidney function checked within 6 months of delivery.

Yet when women were systematically evaluated postpartum in a French-Italian multicenter study, 19% had newly diagnosed CKD. The expected rate in women of childbearing age is around 3%.

We are not finding CKD in these women because we are not looking for it.

Two Tests. A Few Dollars. Years of Difference.

The screening is not complicated or expensive. Two tests cover it: a GFR -- glomerular filtration rate, already included in a standard basic metabolic panel -- and a urine albumin-to-creatinine ratio, known as uACR.

These tests are ordered every day in every clinic. They cost almost nothing. They are just not being ordered for these women, after these pregnancies.

Early CKD is manageable. Blood pressure control slows progression. Certain medications protect kidney function. Lifestyle changes matter. None of this is possible if the diagnosis is never made.

This Is Not a One-Time Postpartum Check

A woman who had preeclampsia at 32 does not need one kidney test at her 6-week visit and then nothing. She needs her pregnancy history to follow her.

At her annual physical at 40. At 45. At 55. Every time a clinician sees her, the question should be on the table: did you have preeclampsia or a pregnancy complication? When were your kidneys last checked?

This is a lifelong conversation that pregnancy history must inform.

What Needs to Change

Awareness unlocks everything. When clinicians understand this connection, they order the right tests. When health systems understand it, they build it into protocols. When women understand it, they can advocate for themselves at any appointment -- at 10 weeks postpartum, at their annual physical, at 45, at 55.

They can walk in and say: I had preeclampsia. Have you checked my kidneys this year?

That sentence, said by an informed woman to any clinician, is enough to start the process. We just need women to know to say it.

My Take

I have spent decades studying what happens to women during pregnancy. I have watched postpartum care shrink to a single visit focused on contraception and blood pressure. I have seen what happens when the complexity of what pregnancy does to a body is treated as something that resolves at discharge.

It does not resolve. It echoes.

Preeclampsia is not a pregnancy problem that ends when the baby arrives. It is a signal that the body sends -- about the cardiovascular system, about the kidneys, about long-term risk -- and we are choosing, through inaction, not to read it.

The tests exist. The evidence exists. The guidelines exist -- in nephrology, if not yet in obstetrics. What is missing is the will to make postpartum care mean something beyond six weeks.

We can fix this. It starts with asking the right questions.

This week: a Doximity thread. Different platform, same unfiltered truth -- except now it is the doctors doing the talking.

Summary

A Philadelphia jury awarded $108.6 million to the family of a brain-injured child in a birth injury case against Jefferson Health. It is the largest med…

Read more

A California doctor is facing felony involuntary manslaughter charges. A two-day-old boy is dead. The cause of death was opioid toxicity from a drug that should never have been anywhere near a newborn during a routine circumcision. This case is a tragedy. It is also a teaching moment that every physician who performs procedures should read carefully.

What Happened

On February 27, 2024, Dr. Hong-An Jan performed a circumcision on two-day-old Charles Wang at his private clinic in Garden Grove, California. According to the lawsuit and court filings, instead of injecting Xylocaine (lidocaine), the appropriate local anesthetic for this procedure, the physician injected Demerol, a synthetic opioid painkiller classified as a Schedule II narcotic. The toxicology report confirmed high levels of Demerol. There was no lidocaine.

The infant became lethargic and unresponsive.

The physician examined him, told the parents this was a normal reaction, sent them home, and ordered no laboratory tests. The following day, Charles was pronounced dead at the hospital. The coroner ruled the cause of death as bronchopneumonia due to acute Demerol intoxication.

Dr. Jan pleaded not guilty in February 2026. His medical license has been suspended pending the outcome of the case.

PS: According to the report, the doctor earned his medical degree in 1967 which would have likely made him about 80 years old in 2024. Commercial airline pilots in the United States are prohibited from flying passengers after age 65 under FAA regulations Federal Aviation Administration — a rule aligned with international aviation standards and based on the straightforward premise that cognitive and physical performance decline with age, and that passengers deserve protection from that risk. Dr. Jan appeared to be in his 80’s when he performed the procedure that killed Charles Wang. There is no equivalent rule for physicians.

A pilot who is 80 years old cannot legally sit in the cockpit of a commercial aircraft.

A physician who is 80 years old can perform procedures on a two-day-old infant in a private office with no oversight, no co-pilot, and no mandatory competency review. Medicine has long resisted what aviation figured out decades ago: that experience and age are not the same thing, and that protecting the public sometimes means protecting it from practitioners who no longer recognize their own limitations.

What does the AARP say

The AAP position on pain control during newborn circumcision is unambiguous and has been for more than two decades. Its 1999 policy statement declared for the first time that analgesia is essential if circumcision is to be performed, citing physiologic evidence that neonates circumcised without pain control experience measurable stress responses including changes in heart rate, blood pressure, oxygen saturation, and cortisol levels. The 2012 AAP Task Force on Circumcision reaffirmed and strengthened this position: adequate analgesia should be provided whenever newborn circumcision is performed, and nonpharmacologic techniques such as positioning and sucrose pacifiers are insufficient as the sole method and should be used only as adjuncts. American Academy of Pediatrics

The three accepted pharmacologic methods are:

1. EMLA cream (a topical lidocaine-prilocaine mixture),

2. the dorsal penile nerve block, and

3. the subcutaneous ring block.

The AAP identifies the ring block as the most effective, while noting that all methods reduce but do not eliminate pain. Circumcision Research Project In this case, none of these methods were used. There was no EMLA, no nerve block, no ring block. What was injected instead was a Schedule II opioid with no role whatsoever in neonatal local anesthesia. The AAP standard was not merely missed. It was replaced by something that killed the child.

Demerol in a Newborn: Why This Is Catastrophic

Meperidine (Demerol) is an opioid analgesic with a narrow therapeutic window in adults. In neonates, it is not just dangerous. It is potentially lethal. Newborns have immature hepatic enzyme systems, particularly CYP2B6 and CYP3A4, which are responsible for metabolizing opioids. They have limited protein binding capacity, meaning a higher fraction of the drug circulates in the free, active form. Their blood-brain barrier is more permeable. The respiratory center in the brainstem is exquisitely sensitive to opioid-induced suppression. A dose that might cause sedation in an older child or adult can cause apnea, hypoxia, and death in a two-day-old.

The medical literature has documented this risk repeatedly. Inadvertent administration of adult opioid doses to neonates and small children is one of the most consistently reported causes of serious adverse outcomes in pediatric patients. The Institute for Safe Medication Practices (ISMP) has published multiple alerts on neonatal opioid overdose from medication errors. The Joint Commission has cited look-alike, sound-alike drug errors as a persistent root cause of sentinel events in newborns and children. This is not obscure knowledge. It is foundational pharmacology.

When an infant is lethargic and unresponsive after a procedure where an opioid has been administered, even inadvertently, even unknowingly, the correct response is emergency evaluation, opioid reversal with naloxone if indicated, and immediate transfer. Not reassurance. Not sending the family home.

The Timeout

Before any procedure, every clinical setting in the United States that follows standard safety protocols requires a formal pre-procedure pause. It is called the Universal Protocol, developed by The Joint Commission and adopted across surgical and procedural medicine. It has three components: a pre-procedure verification, a site marking when applicable, and a time-out immediately before the procedure begins.

The time-out is not bureaucratic theater. It is the last line of defense before a wrong drug, wrong site, wrong patient, or wrong procedure causes permanent harm. During the time-out, the team verbally confirms the patient identity, the planned procedure, and the medications and materials that are about to be used. If the medication drawn into that syringe had been verbally confirmed against the intended agent, the error might have been caught. A nurse saying out loud, ‘Lidocaine, 1%, ready for dorsal penile nerve block,’ is not a formality. It is a checkpoint.

The Universal Protocol was introduced in 2003 after the Joint Commission’s analysis of wrong-site surgeries. Subsequent data showed meaningful reductions in surgical errors at institutions that implemented it rigorously. The WHO Surgical Safety Checklist, adapted globally since 2008, incorporates the same logic. The evidence for structured checklists in procedural safety is not debated. Atul Gawande’s work popularized it; the aviation industry proved it decades earlier. Checklists save lives.

Private office-based procedures present a specific risk here.

Hospitals and ambulatory surgical centers have protocols enforced by accreditation standards, nursing staff, and institutional oversight.

A solo practitioner in a private clinic may have none of those safeguards. No scrub tech to confirm the tray. No circulating nurse to verify the drug. No second set of eyes at the moment the syringe is filled.

This is precisely where a personal pre-procedure time-out, even performed alone and spoken aloud, becomes non-negotiable.

If Dr. Jan had paused before the procedure, looked at the syringe, and confirmed aloud, ‘This is Xylocaine, I am about to perform a dorsal penile nerve block on a two-day-old male for circumcision,’ the question arises whether the wrong drug would have made it into that child’s tissue. We cannot know. But we know that no protocol protected him.

Medication Safety in Newborns and Small Children

Neonates and infants are pharmacologically not small adults. Drug dosing errors in this population are a well-documented patient safety crisis. A 2019 systematic review published in BMJ Quality and Safety found that medication errors in neonatal intensive care units had an incidence ranging from 3 to 73 per 1,000 patient-days across studies, with administration errors being the most common type. ISMP has repeatedly highlighted that neonates are at the highest risk of fatal medication errors precisely because small dose differences produce dramatic clinical consequences.

In the outpatient procedure setting, the risks multiply when there is no pharmacist verification, no unit-dose dispensing system, and no barcode medication administration. In a solo private office, the physician draws the drug, carries the syringe, and administers it without any of the institutional checks that exist in hospital settings. This is legal. It is common. And in the absence of personal discipline and double-checking, it is dangerous.

Opioids and local anesthetics are not look-alike medications by name, but they may share packaging, syringe sizes, or storage proximity in a small office. ISMP has long advocated for physical separation of high-alert medications in clinical environments. High-alert drugs, including opioids, concentrated electrolytes, and anticoagulants, warrant special storage, labeling, and handling precisely because the consequences of error are severe and irreversible.

What Should Have Happened at Discharge

Even if the medication error had occurred and gone undetected at the time of the procedure, the subsequent encounter with the parents represented a second opportunity to avert the outcome. A lethargic, unresponsive newborn in the hours after a procedure is a medical emergency until proven otherwise. The clinical response to that presentation is not visual inspection and verbal reassurance. It is vital signs, oxygen saturation, a thorough neurological assessment, and if opioid exposure is possible under any circumstances, naloxone consideration and urgent escalation.

The lawsuit alleges that the physician neither drew blood nor ordered laboratory studies despite observing symptoms consistent with opioid toxicity. If that is accurate, this is not a close clinical call. It is a failure of the most basic principles of emergency recognition.

My Take

I have performed procedures throughout my career. I have taught residents to perform procedures. The pre-procedure time-out is not something you do because your institution requires it. It is something you do because the alternative is standing in a courtroom explaining why you did not.

Charles Wang was two days old. He did not need to die. The procedural error that killed him may have been prevented by a single verbal confirmation before the procedure began. The failure to recognize and act on his deteriorating condition afterward compounded a catastrophe that was already unfolding.

This case will move through the courts. Dr. Jan has pleaded not guilty and is entitled to due process. But regardless of how the criminal matter resolves, the clinical lessons are not ambiguous. Every physician performing procedures, in a hospital, an ambulatory center, or a private office, should treat the pre-procedure time-out as inviolable. Every practice that stocks opioids alongside other injectable agents should have physical separation and mandatory double-checks before administration. And every clinician who encounters a lethargic newborn after any procedure should treat it as a crisis, not a reassurance opportunity.

Checklists are not an insult to expertise. They are what expertise looks like when it takes safety seriously.

Addendum

Drug dosing in neonates, children, and adults is not a sliding scale. It is a fundamentally different calculation at every stage of development, and the margin for error collapses as the patient gets smaller.

A standard adult dose of an opioid is calculated for a body weighing roughly 70 kilograms with mature hepatic enzyme systems, full protein binding capacity, and a blood-brain barrier that has had decades to consolidate. A two-day-old weighs approximately 3 kilograms. That is a more than 20-fold difference in body mass alone. But weight is only the beginning. Neonatal and pediatric patients can vary in weight from 0.5 kg to over 100 kg, creating the potential for a 400-fold dosing error, compared to a maximum of roughly 2-fold in adult patients.

PubMed Central In neonates specifically, the cytochrome P450 enzyme system that metabolizes opioids is functionally immature at birth and does not reach adult capacity for weeks to months depending on the specific enzyme. Renal clearance is similarly limited. A tenfold dosing error in a child can occur from a single misplaced decimal point and may go undetected because the resulting dose still falls within the normal adult range NCBI — a range that is physiologically lethal in a newborn.

This is precisely why weight-based dosing in mg/kg is mandatory in pediatric pharmacology, why neonates require entirely separate dosing references, and why any opioid administered to a newborn outside of a controlled neonatal intensive care setting with continuous monitoring is a high-alert event by definition. In a private office, with no pharmacist, no barcode verification, and no second check, that margin for catastrophic error is entirely dependent on the physician drawing the correct drug into the correct syringe. In this case, that did not happen.

Reddit is where patients go at 2 a.m. when scared. I monitor dozens of communities for clinically meaningful posts: dangerous myths, gaps between belief and evidence, stories guidelines cannot capture. This series -- ObGyn Intelligence on Reddit -- dissects them against the literature, because ObGyns who ignore social media ignore the most unfiltered window into what patients think, fear, and do between appointments.

Summary

Four Reddit posts from r/homebirth -- posted within the last 1-2 years -- describe what happened when planned home deliveries went wrong. You never get that information from midwives.

The mothers had different backgrounds and different midwives, but their stories share a troubling pattern: prolonged, complicated labors managed outside the hospital without timely escalation, followed by neonatal distress, NICU admissions, and in one devastating case, the death of a newborn son at three days of life.

Across all four accounts, women describe feeling abandoned by their midwives after transfer, receiving little or no informed consent about escalating risk, and blaming themselves for outcomes that were not their fault.

The community’s response was overwhelmingly empathetic -- but almost universally failed to name the systemic failures these stories document.

These are not outliers. They are a window into a regulatory and accountability gap that costs lives.

I created several tools on tools.obmd.com for women considering homebirth:

• Home Birth Eligibility Checklist (Am I eligible?)

• Home Birth Informed Consent

The rest of this post is for paid subscribers. What follows are insights into what homebirth in the US looks like.

Read more

In 2018 and 2019, two women in Kings County, California -- both struggling with methamphetamine addiction -- delivered stillborn babies and were charged with murder by District Attorney Keith Fagundes under a California fetal murder statute originally written to protect pregnant women from assault. One woman, Adora Perez, served nearly four years in prison after a guilty plea to manslaughter. The other, Chelsea Becker, spent 16 months in pretrial detention on a $2 million bail before her murder charge was dismissed. Both convictions were eventually overturned. The DA invoked a law meant to protect pregnant women from third-party violence and turned it against the mothers themselves. When asked why, he said: “Somebody’s gotta be a voice for that fetus.” That one sentence generated 51,000 upvotes and nearly 3,000 comments on Reddit’s r/politics. The thread became a proxy for the national conversation about reproductive rights, drug addiction, and who gets to decide when a pregnancy becomes a crime scene.

The rest of this post is for paid subscribers.

Read more

A new mother in Amsterdam goes home two days after delivery. A trained obstetric nurse visits her at home the next day. She checks blood pressure, inspects the wound, screens for depression, examines the baby, and reviews feeding. She is licensed. She is accountable. She is paid by the health system. She comes back several times in the first ten days.

Now consider a new mother in Boston. She may or may not get a six-week postpartum visit. If she is on Medicaid, she is statistically less likely to show up. Nobody comes to her home with a stethoscope. What the system offers instead, increasingly, is a doula.

A well-meaning doula. But not a nurse.

What the Paper Says

A viewpoint published in Pregnancy (Anghel et al., 2026) [the official journal of the Society for Maternal-Fetal Medicine] compares three postpartum support roles: doulas, community health workers (CHWs), and patient navigators. Not nurses. The authors from Brigham and Women’s Hospital and Harvard Medical School argue that these roles are distinct, underutilized, and potentially complementary. They use Massachusetts Medicaid as a case study and call for better standardization of training and reimbursement.

The tone is measured, the analysis thoughtful, and the intentions plainly good.

And yet the paper, almost entirely without meaning to, makes a case that should trouble us deeply.

The Central Problem: We Are Normalizing Less Care

The United States has one of the worst maternal mortality rates in the developed world. According to the CDC, the maternal mortality rate in 2022 was 22.3 deaths per 100,000 live births. In Germany it is 4. In the Netherlands it is 4. In Sweden it is 5. Many of those deaths happen in the postpartum period, not in the delivery room.

Now look at what those countries do differently after birth. In the Netherlands, the kraamzorg system sends a trained maternity nurse to every new mother’s home for 8 to 10 days after delivery. In Germany and other European countries, midwives and obstetric nurses provide structured home visits in the weeks after birth. These are not volunteers. They are not peer supporters. They are trained clinical professionals.

So what does American medicine do when postpartum care fails the most vulnerable patients? It does not ask why we cannot fund postpartum nurses. It proposes doulas.

I want to be precise here. Doulas can play a real role in emotional support, advocacy, and continuity of care. The data cited in this paper shows that among Medicaid enrollees, doula care is linked to a 47% lower risk of cesarean delivery and improved postpartum visit attendance. These are not trivial numbers. But those outcomes reflect a system so broken that the presence of any continuous human support produces measurable benefit. That is not an argument for doulas. That is an indictment of the baseline.

Medical Training Is Not Optional for High-Risk Patients

Here is the part of this conversation that almost nobody says plainly: postpartum patients are not low-risk until proven otherwise.

Preeclampsia can present or worsen after delivery.

Postpartum hemorrhage kills.

Postpartum cardiomyopathy is underdiagnosed.

Postpartum depression is missed at rates that should embarrass our system.

Sepsis does not wait for a six-week visit.

A doula is trained to provide emotional support, comfort, and information. Massachusetts requires doulas to demonstrate a basic understanding of maternal anatomy and common complications. That is a reasonable credential for an emotional support role. It is not a reasonable credential for identifying early signs of hypertensive emergency, evaluating wound dehiscence, assessing postpartum hemorrhage, or recognizing sepsis.

The paper itself acknowledges that doula competencies do not include clinical care coordination. Their role is explicitly described as non-clinical.

So why are we treating non-clinical workers as the solution to a clinical crisis?

The Equity Argument Cuts Both Ways

Proponents of this model frame it as an equity intervention. Rates of postpartum visit attendance are lower for Medicaid-insured and racially minoritized patients.

The system fails them.

Doulas and community health workers can help bridge that gap.

The argument has genuine merit, and I do not dismiss it.

But consider what we are really saying: the patients most at risk get the least-trained support.

Wealthy privately insured patients get board-certified obstetricians and nurses at every touchpoint.

Medicaid patients get a doula reimbursed at up to $1,700 for the entire perinatal period, with no standardized national competencies and no requirement for clinical training. The ones more at risk get less care.

This is not equity. It is a two-tier system given a compassionate name.

The paper rightly notes that the largest variations in postpartum care affect those with multiple disadvantaged identities.

The correct response to that finding must be to demand that Medicaid fund the same standard of clinical postpartum care available to well-insured patients. Not to build an elaborate non-clinical workforce and call it innovation.

What We Should Actually Be Demanding

The Netherlands spends money on kraamzorg nurses because Dutch society decided postpartum care is a clinical right, not a privilege. The result is a maternal mortality rate roughly five times lower than ours.

We should be demanding universal Medicaid reimbursement for structured postpartum home visits by trained nurses or certified nurse midwives in the first two weeks after birth.

We should be demanding parity between Medicaid reimbursement rates and private insurance rates so that qualified clinicians have the financial incentive to serve these patients. We should be demanding national standards that treat postpartum monitoring as the medical necessity it is.

Instead, the conversation has drifted toward how to credential a doula in Colorado versus Delaware, and whether patient navigators should be reimbursed separately from community health workers.

These are not unimportant questions.

But they are not the right question.

The right question is why the richest country on earth decided that trained nurses are optional for new mothers on Medicaid.

What the Paper Gets Right

To be fair to Anghel and colleagues: they are not arguing that doulas replace nurses. They are making the narrower case that if these roles exist, we should define them clearly and fund them appropriately. That is a reasonable argument within the constraints of a system that is not going to suddenly fund universal nurse home visits.

They are also right that CHWs and patient navigators bring real value in clinical navigation and referral, and that their competencies differ meaningfully from doulas. Better defining these roles is useful. The call for standardized training and cost-effectiveness data is sensible.

The problem is not this paper. The problem is the system this paper is trying to improve by working around it.

My Take

I have delivered more than 10,000 babies. I have watched more women leave the hospital without adequate postpartum follow-up than I care to count. I have been involved when women died postpartum. The fourth trimester is not a wellness concept.

Postpartum is a high-risk clinical period that kills women.

I am not against doulas.

I am against a medical system that uses them as a substitute for trained clinical postpartum care and then presents that substitution as progress for underserved communities.

The European comparison is not a fantasy. It is an existence proof. Postpartum nurse home visits work. They exist. They are funded by governments that decided maternal lives are worth the cost. We have decided something different, and we dress it up in the language of equity and innovation rather than call it what it is: a failure to fund adequate medical care.

The next time someone tells you that expanding the doula workforce is the answer to America’s maternal mortality crisis, ask them a simple question:

Would they be comfortable with their own spouse or daughter going home after delivery with only doula support or would they prefer that she be seen by a nurse?

Would you be comfortable going home after delivery with only doula support or would you prefer like in Europe to be seen by a nurse?

If the answer is no, then we should say so clearly, loudly, and without apology.

Reference

Anghel EM, Zera CA, Lara MC, Celi AC. Comparing postpartum support roles: Matching strengths to need. Pregnancy. 2026;2:e70269. doi:10.1002/pmf2.70269

That pi…

Read more

Twin delivery planning involves two separate decisions that are often collapsed into one:

1. timing (what week) and

2. mode (vaginal or cesarean).

Both depend on many circumstances such as chorionicity, fetal position, whether complications have developed, and the experience of your delivery team. Patients are frequently told a delivery week without understanding why that number was chosen. This post gives you the numbers behind those decisions.

The Delivery Clock: Different Twins, Different Weeks

Every twin pregnancy has a gestational age beyond which the risk of continuing the pregnancy exceeds the risk of delivery. That threshold is different for each placental type, and it was not established by opinion. It was established by data showing when stillbirth risk begins to outweigh neonatal complications from early delivery.

A systematic review and meta-analysis of 32 studies covering 35,171 twin pregnancies found the following: in dichorionic twins, the risk of stillbirth from watchful waiting and the risk of neonatal death from delivery were balanced at 37 weeks. Delaying delivery by just one additional week, to 38 weeks, resulted in an additional 8.8 perinatal deaths per 1,000 pregnancies (1). That is not a theoretical risk. That is a measurable increase in death from waiting one week too long.

Here is what the evidence supports for uncomplicated twin pregnancies:

• Dichorionic-diamniotic twins: Delivery at 37 to 38 weeks. ACOG recommends 38 weeks 0 days to 38 weeks 6 days. NICE and RCOG recommend from 37 weeks. The evidence favors not going past 38 weeks (1,2,3).

• Monochorionic-diamniotic twins: Delivery at 36 to 37 weeks. The RCOG 2024 update recommends planned birth between 36 weeks 0 days and 36 weeks 6 days. ISUOG 2025 supports the same window. ACOG recommends 36 weeks 0 days to 37 weeks 6 days (2,3,4).

• Monochorionic-monoamniotic twins: Delivery at 32 to 34 weeks by planned cesarean. Both ACOG and RCOG recommend this range. The reason is the persistent risk of cord entanglement and acute cord compression, which cannot be predicted by any antenatal test and which can cause sudden fetal death (2,4,5).

These are the dates for uncomplicated pregnancies. When complications develop, delivery moves earlier.

When Complications Change the Timeline

The delivery week listed above applies only when everything remains normal. Twins are prone to complications that singleton pregnancies either do not face or face at lower rates. When these complications appear, the delivery date moves forward, sometimes by weeks.

Preeclampsia and Hypertensive Disorders

Preeclampsia occurs more frequently in twin pregnancies than in singletons. When it develops, delivery timing follows the severity, not the twin schedule.

Gestational hypertension without severe features: delivery at 37 weeks (same as singleton management, which in twins may already be the planned delivery date for di-di twins). Preeclampsia without severe features: delivery at 37 weeks 0 days, or earlier if the clinical picture worsens. Preeclampsia with severe features: delivery at 34 weeks 0 days, or sooner if the mother or fetuses are unstable. HELLP syndrome or eclampsia: delivery after maternal stabilization regardless of gestational age (6).

In a twin pregnancy, preeclampsia can mean the planned delivery date becomes irrelevant. A mono-di twin pregnancy that was expected to deliver at 36 weeks may need delivery at 32 weeks because of worsening maternal blood pressures, rising liver enzymes, or dropping platelet counts. This is not a failure of the plan. It is the plan responding to maternal physiology.

Fetal Growth Restriction

Growth restriction in twins must be evaluated by chorionicity because the implications differ.

In dichorionic twins, fetal growth restriction behaves like singleton growth restriction. The fetuses have separate circulations, so one twin’s growth problem does not directly affect the other. Delivery depends on the severity: if the umbilical artery Doppler shows positive end-diastolic flow, close surveillance continues and delivery is considered at 37 weeks. If there is absent end-diastolic flow, delivery at 34 weeks. If there is reversed end-diastolic flow, delivery at 32 weeks or earlier depending on other findings (3,4,7).

In monochorionic twins, growth restriction is a different and more dangerous entity called selective fetal growth restriction (sFGR). Because the twins share a circulation through placental vascular connections, growth restriction in one twin can affect both. The RCOG classifies sFGR in monochorionic twins by umbilical artery Doppler pattern (4):

Type I sFGR (positive end-diastolic flow in the umbilical artery of the smaller twin): Generally favorable prognosis. Planned birth between 34 to 36 weeks if growth velocity is satisfactory and Dopplers remain normal. Type II sFGR (persistent absent or reversed end-diastolic flow): High risk of sudden deterioration and co-twin injury. Referral to a fetal medicine center for possible laser ablation or cord occlusion. Delivery often at 32 weeks or earlier. Type III sFGR (intermittent absent or reversed end-diastolic flow): Unpredictable. Requires close surveillance and individualized timing.

The key difference from singleton FGR is that in monochorionic twins, if one twin dies from growth restriction, the surviving twin is at risk of acute brain injury or death because blood can shift rapidly through the placental connections. That risk does not exist in dichorionic twins.

Twin-to-Twin Transfusion Syndrome (TTTS)

TTTS that requires laser treatment changes the delivery timeline based on what happens after the procedure. If laser treatment is successful and the pregnancy stabilizes, delivery is typically planned at 34 to 36 weeks. If complications develop after laser (recurrent TTTS, TAPS, preterm rupture of membranes), delivery may be needed earlier. If TTTS is diagnosed too late for laser (after 26 weeks at many centers), delivery timing depends on the severity and response to other interventions such as amnioreduction (8).

TTTS that is detected but remains at stage I (fluid discordance only) may be managed expectantly with very close surveillance, as approximately one-third of stage I cases resolve, one-third remain stable, and one-third progress (8).

Growth Discordance

Growth discordance, defined as a 25% or greater difference in estimated fetal weight between the twins, is a separate risk factor from growth restriction. One twin may be above the 10th percentile while the other is significantly larger. Even without one twin being technically “growth restricted,” a 25% or greater discordance independently increases the risk of adverse outcomes and typically moves delivery earlier, to 36 to 37 weeks for dichorionic twins and 34 to 36 weeks for monochorionic twins (3,4).

Read more

What you are almost never told, at least not clearly enough and not early enough, is that twin risk has almost nothing to do with the number of babies. It has everything to do with the placenta.

One Question Changes Everything

The single most important piece of information in any twin pregnancy is chorionicity: how many placentas are there, and how many amniotic sacs surround the babies?

This is not a detail. It is the foundation of your entire prenatal care plan. It determines how often you are scanned, what your doctors are looking for at each visit, when you will deliver, and what complications can develop between one appointment and the next.

First-trimester ultrasound between 11 and 14 weeks can determine chorionicity with 99.8% accuracy (1). After 14 weeks, that accuracy drops because the membranes between twins become harder to distinguish. A study that confirmed chorionicity by placental pathology or discordant sex in 613 pregnancies found only one misclassification in the entire cohort when the scan was performed in the first trimester (1).

That means there is a narrow window to get this right. If your provider does not determine chorionicity before 14 weeks, you may spend the rest of your pregnancy in the wrong monitoring lane.

Three Types of Twins, Three Different Pregnancies

Twins are classified by biology, not by how many babies there are.

• Dichorionic-diamniotic (di-di) twins have two separate placentas and two separate amniotic sacs. This includes virtually all fraternal twins and roughly one-third of identical twins. Because each fetus has its own blood supply, these twins are physiologically independent. The risks are real, including preterm birth, growth differences, and preeclampsia, but they are the lowest-risk twin configuration.

• Monochorionic-diamniotic (mono-di) twins share a single placenta but have separate amniotic sacs. This occurs in about two-thirds of identical twins. Because the placenta is shared, blood vessels connect the two fetal circulations. Over 95% of monochorionic placentas have vascular anastomoses linking the twins (2). That single anatomic fact changes everything about how these pregnancies behave. One twin can transfuse blood to the other. One twin can grow while the other falls behind. And the transition from normal to dangerous can happen in days, not weeks.

• Monochorionic-monoamniotic (mono-mono) twins share one placenta and one amniotic sac. There is no dividing membrane. The cords can entangle. These pregnancies account for about 1% of all twins and roughly 5% of monochorionic twins (3). Cord entanglement is present in virtually 100% of mono-mono pregnancies when systematically evaluated by ultrasound and color Doppler (4). This is among the highest-risk situations in modern obstetrics.

Why Monitoring Differs by Placental Type

The monitoring schedule for twins is not about doing more ultrasounds. It is about looking for specific complications that are biologically possible only in certain placental configurations. A di-di twin who looks healthy at 24 weeks is unlikely to develop a sudden placental crisis at 26 weeks. A mono-di twin can look completely normal at one visit and show early twin-to-twin transfusion syndrome two weeks later.

This post is part of the “High Risk Pregnancy and Know Your Numbers, Trust Your Body” series. Subscribe to ObGyn Intelligence for the full analysis, including what TTTS looks like, what your monitoring schedule should catch, and the delivery timing numbers you need to bring to your next appointment.

Read more

In some offices, the conversation is short: the doctor says no, lists the dangers, and moves on. In others, the midwife says yes, lists the comforts, and moves on. In both cases, the woman leaves with an incomplete picture. And in both cases, someone has failed her — not because of what they recommended, but because of what they didn’t explain.

The home birth debate in the United States has hardened into opposing camps. On one side, an obstetric establishment that treats the request as reckless. On the other, a natural birth movement that frames hospital birth as inherently interventionist and traumatic. Both sides claim the evidence. Neither side does a great job of presenting it fairly.

I want to try something different.

Autonomy is not the end of the conversation

Let me be clear about my starting position: every woman has the right to decide where she gives birth. ACOG says this explicitly in Committee Opinion No. 697: “Each woman has the right to make a medically informed decision about delivery.” I agree.

But notice the modifier: medically informed. Autonomy without information is not autonomy — it is abandonment dressed up as empowerment. A woman who chooses home birth because she was told it is “just as safe” has not been given the foundation for an autonomous decision. Nor has a woman who chooses the hospital solely because her doctor said home birth is “crazy” without explaining the actual data.

True informed consent requires three things: disclosure of relevant information, comprehension by the patient, and voluntary decision-making free from coercion. In the home birth conversation, all three are routinely violated. Providers on both sides disclose selectively, confirm what they already believe, and — subtly or overtly — steer.

What the evidence actually shows

The honest answer is that the evidence is mixed, and how you interpret it depends heavily on which country you’re talking about.

In integrated health systems like the Netherlands, the United Kingdom, and parts of Canada — where certified midwives have hospital privileges, standardized transfer protocols exist, and transport times are short — studies show comparable perinatal outcomes for planned home births among low-risk women. The large Birthplace in England study and multiple Dutch cohort studies support this conclusion, and the most comprehensive meta-analysis (Hutton et al., EClinicalMedicine 2019) found no difference in perinatal or neonatal mortality for intended home versus hospital births within these systems.

The United States is not one of those systems.

In the US, Wax et al. (AJOG 2010) found that planned home births had fewer interventions but a nearly threefold increase in neonatal mortality among nonanomalous infants. Grünebaum et al., using CDC linked birth-infant death data from 2010–2017, found neonatal mortality of 3.27 per 10,000 for hospital midwife-attended births versus 13.66 per 10,000 for all planned home births — a more than fourfold difference. Critically, this difference persisted regardless of whether the home birth was attended by a certified nurse-midwife or a direct-entry midwife.

ACOG’s own summary: planned home birth is associated with “a more than twofold increased risk of perinatal death (1–2 in 1,000) and a threefold increased risk of neonatal seizures or serious neurologic dysfunction.”

Why the discrepancy between countries? The answer is not the mothers or the midwives — it is the system. In the Netherlands, a midwife recognizing a complication can have the patient in an operating room within 15 minutes. In large swaths of the United States, that transfer might take 45 minutes to an hour — or longer. The midwifery credential varies wildly by state. There is no national requirement for hospital integration. The safety net has gaps.

This does not mean home birth is indefensible in the United States. It means that its safety depends on a specific set of conditions being met — and those conditions are far more demanding than most discussions acknowledge.

The problem with both sides

The natural birth community tends to emphasize the advantages: fewer interventions, lower cesarean rates, continuous support, freedom of movement, familiar environment. These are real. The meta-analyses consistently show fewer episiotomies, less oxytocin augmentation, fewer operative deliveries, and lower infection rates in planned home births. For a woman who has had a traumatic hospital experience, these are not trivial considerations.

But the movement frequently minimizes the disadvantages. No epidural availability. No continuous fetal monitoring. No cesarean capability. No neonatal resuscitation team. No blood bank. Transfer rates of 10–37% for first-time mothers — meaning up to one in three will end up in the hospital anyway, but now with a delay that may have consequences. The planned home birth of a breech-presenting fetus carries an intrapartum mortality of 13.5 per 1,000. These numbers are often absent from the “informed choice” materials handed to expectant mothers by home birth advocates.

The obstetric establishment, meanwhile, too often dismisses the request without engaging with it. “Just have the baby in the hospital” is not informed consent. It is paternalism. And paternalism — even well-intentioned paternalism — erodes exactly the trust that makes hospital birth safe. A woman who feels unheard is a woman who may stop communicating with her providers, decline monitoring, or make decisions in isolation. We cannot protect patients by shutting them out of the conversation.

What informed consent actually requires

The ethics here are not complicated. They are just inconvenient.

Informed consent for planned home birth requires disclosing the advantages and the disadvantages — all of them. It requires presenting the data in absolute terms, not just relative risk. It requires acknowledging what we don’t know (there has never been an adequate randomized trial). It requires confirming that the patient understands the specific conditions under which home birth is reasonable — and the specific conditions that make it dangerous.

Most importantly, it requires a systematic approach. Currently, the “informed consent” for home birth is often a conversation — variable in content, dependent on the provider’s perspective, and rarely documented in a way that ensures completeness. A woman might hear about the lower cesarean rate but not the higher neonatal mortality. She might hear that transfer is available but not that transfer times in her area exceed 30 minutes. She might be told she’s “low risk” without anyone systematically verifying that she meets the criteria that make that designation meaningful.

This is where we saw a gap, and why we built two tools.

Two tools for a better conversation

The Home Birth Informed Consent Tool presents 10 evidence-based advantages and 20 evidence-based disadvantages of planned home birth, each requiring individual acknowledgment. The advantages are real and drawn from published meta-analyses: lower intervention rates, higher spontaneous vaginal delivery rates, continuous one-on-one midwifery support, familiar environment. The disadvantages are equally evidence-based and include the items that are most frequently omitted from home birth counseling: the absence of cesarean capability, neonatal resuscitation limitations, the twofold to threefold increase in neonatal mortality in US data, the 10–37% transfer rate, and the absence of adequate pain relief options. Every item must be individually checked before the consent is complete. You cannot skip what is uncomfortable.

The Home Birth Eligibility Checklist takes a different approach. Instead of asking the woman to understand the risks in the abstract, it asks her to verify — one item at a time — that she meets the specific pre-labor conditions required for home birth to be appropriate. Twenty-eight items across three categories: maternal health (no hypertension, no diabetes requiring insulin, no cardiac disease, no prior cesarean, BMI under 40), obstetric history (no prior shoulder dystocia, no prior fourth-degree tear), and current pregnancy (singleton, cephalic, term, no preeclampsia, no placenta previa, no fetal growth restriction, adequate prenatal care). Every unchecked item generates a specific explanation of why it contraindicates home birth — not a vague warning, but a precise clinical rationale.

The tool then goes further: even if all 28 pre-labor criteria are met, the report displays the intrapartum conditions that must remain true during labor (clear fluid, no fever, no need for augmentation, appropriate labor progress, no fetal heart rate abnormalities) and the system and logistics requirements that must be in place (licensed attendant, neonatal resuscitation capability, uterotonic medications, pre-arranged transport plan, receiving hospital within 20–30 minutes).

The framework concludes with a statement that matters: This does not claim hospital birth is required for everyone. It defines something narrower — a pregnancy in which clinicians can reasonably expect a spontaneous vaginal delivery that will not depend on immediate surgical, anesthesia, blood bank, or neonatal resuscitation resources.

That is the actual eligibility question. Not “Do you want a home birth?” but “Is there a reasonable clinical basis for expecting that you will not need resources that are only available in a hospital?”

Respecting autonomy means respecting the patient

The deepest irony of the home birth debate is that both sides claim to be protecting women’s autonomy while neither side consistently does the work that autonomy demands.

Respecting a woman’s autonomy is not telling a woman what to do. It is also not telling her whatever she wants to hear. It is making sure she has the information — the real information, presented honestly, completely, and in a way she can understand — and then respecting her decision.

A woman who reviews 20 specific risks, checks each one to confirm she understands it, verifies that she meets 28 eligibility criteria, understands the intrapartum conditions that must hold, and still chooses home birth — that woman has made an informed decision. Her autonomy is robust. Her providers can support her plan with a clear conscience.

A woman who was told “home birth is beautiful and safe” and is being lied to that studies show it’s safe (these studies are not US-based studies and most women are not told that the US system is way different) and signed a generic consent form has not made an informed decision.

Her autonomy has been undermined by incomplete information, regardless of how empowering the language felt.

We built these tools because the conversation deserves better than ideology. Both tools are free and available online. Use them. Share them with your patients. Share them with colleagues. If you think something is missing, tell us.

The goal is not to prevent home births. The goal is to make sure that every woman who chooses one does so with her eyes open.

References

1. ACOG Committee Opinion No. 697. Planned Home Birth. Obstet Gynecol. 2017;129(4):e117-e122.

2. Wax JR, Lucas FL, Lamont M, et al. Maternal and newborn outcomes in planned home birth vs planned hospital births: a metaanalysis. Am J Obstet Gynecol. 2010;203(3):243.e1-8.

3. Grünebaum A, McCullough LB, Arabin B, Chervenak FA. Neonatal mortality in the United States is related to location of birth rather than the type of birth attendant. Am J Obstet Gynecol. 2020;223(2):254.e1-8.

4. Hutton EK, Reitsma A, Simioni J, et al. Perinatal or neonatal mortality among women who intend at the onset of labour to give birth at home compared to women of low obstetrical risk who intend to give birth in hospital: a systematic review and meta-analyses. EClinicalMedicine. 2019;14:59-70.

5. Snowden JM, Tilden EL, Snyder J, et al. Planned out-of-hospital birth and birth outcomes. N Engl J Med. 2015;373(27):2642-2653.

6. Grünebaum A, McCullough LB, Brent RL, et al. Perinatal risks of planned home births in the United States. Am J Obstet Gynecol. 2015;212(3):350.e1-6.

7. Janssen PA, Saxell L, Page LA, et al. Outcomes of planned home birth with registered midwife versus planned hospital birth with midwife or physician. CMAJ. 2009;181(6-7):377-383.

8. Chervenak FA, McCullough LB, Brent RL, et al. Planned home birth: the professional responsibility response. Am J Obstet Gynecol. 2013;208(1):31-38.

Post Summary

A lawyer and mother of four discovered years after delivery that placental pathology reports from two births (2021: large infarcts; 2022: fetal vascular malperfusion) showed significant abnormalities that no provider ever communicated to her. The unreported findings directly affected managemen…

Read more

Summary

A first-time mother posted that her baby was born with an APGAR score of 0 after an emergency cesarean delivery. She described two to three hours of labor during which the baby’s heart rate dropped with every contraction. Her epidural had fallen out, she was laboring unmedicated, and she says no one ment…

Read more

It was New Year’s Eve. The phone rang. A woman in her 35th week, a patient of a colleague for whom I covered that night — she hadn’t felt her baby move.

I told her to come in.

When she arrived, I placed the ultrasound probe on her belly and saw what I was afraid I would see. No heartbeat. Her baby had died.

I put the probe down. I looked at her. And I told her what she already feared — her baby’s heart had stopped. There was no heartbeat.

Then I said: “I am so sorry this happened.”

That was over twenty years ago. I don’t remember what she was wearing. I don’t remember the exact time. But I remember her face. I remember the silence in that room. And I remember that in that moment, there was nothing to fix, nothing to explain — only a woman who needed someone to be present with her in the worst moment of her life.

I have thought about that night many times since.

And what I’ve come to understand is something Maya Angelou said better than anyone: people forget what you said, people forget what you did, but they never forget how you made them feel.

In obstetrics, that truth is carved into every loss I’ve witnessed.

What people say (and why it hurts)

• “Everything happens for a reason.”

• “At least it was early.”

• “You can always try again.”

• “It wasn’t really a baby yet.”

• “It was meant to happen.”

• “At least you know you can get pregnant.”

Every one of these sentences is meant to comfort. Every one of them lands like a door being closed. What the grieving person hears is: Your pain is not that serious. Move on.

Here’s what I’ve learned after decades in obstetrics: there is no ranking system for grief. A loss at six weeks can shatter someone just as completely as a loss at twenty-six weeks. The depth of grief doesn’t scale with gestational age. It scales with love. And love starts whenever it starts.

When we minimize that — even with the best intentions — we tell someone that what they’re feeling is wrong. That’s a wound on top of a wound.

What silence can do

Sometimes the most powerful thing you can say is nothing.

Not an awkward, avoidant nothing. Not the kind of silence that comes from pretending it didn’t happen. I mean the kind of silence that says: I’m here. I see you. I’m not going anywhere.

Sit with them. Let the room be quiet. Let them cry or not cry. Let them talk or not talk. Your presence is the message.

This is incredibly hard for doctors. We are trained to fix. We are trained to have answers. When someone is hemorrhaging, we act. When someone is grieving, the instinct is the same — do something, say something, make it better.

But grief is not a hemorrhage. You cannot stop it with pressure. You can only be there while it flows.

What actually helps

If you need words — and sometimes you do — here are a few that tend to land gently:

“I’m so sorry.” Simple. Honest. It doesn’t try to explain or fix.

“This is not your fault.” Many people who lose a pregnancy blame themselves. They wonder if they exercised too much, ate the wrong thing, didn’t rest enough. They carry guilt that has no basis in reality. Hearing a doctor say clearly that this was not their fault can be one of the most important things they ever hear.

“I’m here for whatever you need.” And then follow through.

“Would you like to see the baby?” For later losses, this question — asked gently, without pressure in either direction — gives back a measure of control in a moment where everything feels out of control. Some families find deep comfort in holding their baby. Others don’t. Both are okay.

“Can I call someone for you?” Practical help. A partner, a parent, a friend. Sometimes the person in the room can’t think clearly enough to make a phone call.

Use the baby’s name, if they’ve chosen one. This is a small thing that carries enormous weight. It says: Your baby was real. Your baby mattered.

A word to clinicians

We set the tone.

When a patient loses a pregnancy, they are watching us. They are reading our faces, our body language, the speed of our words. They are storing every detail in a kind of emotional amber that will preserve this moment for the rest of their lives.

I have had patients come back to me years later and quote, word for word, something I said after their loss. Not the medical explanation. Not the plan for follow-up. The human part. The sentence that made them feel seen — or the sentence that made them feel dismissed.

This means we carry a responsibility that goes beyond the clinical. When we walk into that room, we are not just delivering information. We are shaping a memory that this person will carry forever.

We don’t need perfect words. We need to be fully present. To slow down. To let go of the reflex to reassure, and instead just be there with someone in their pain.

The takeaway

Pregnancy loss is one of the most common and most isolating experiences in medicine. Roughly one in four known pregnancies ends in loss. That’s millions of people every year walking through grief that our culture still struggles to talk about.

You don’t need a script. You don’t need to fix it. You need to show up with honesty and stay.

“I’m sorry” is almost always enough to start.

And if you’re not sure what to say? Say that. “I don’t know the right words, but I want you to know I care.” That sentence, said with sincerity, does more than any platitude ever could.

Because in the end, they won’t remember the exact words. They’ll remember that you stayed. They’ll remember that you didn’t look away. They’ll remember that in the worst moment of their life, someone made them feel like they weren’t alone.

Post Summary

A screenshot shows a social media exchange in which a woman shares the story of someone who died in childbirth and wanted to live even if it meant losing the baby. A male commenter dismisses the danger entirely, claiming it’s “almost impossible to die in childbirth these days” unless from “sudden cerebral or arterial stroke,” and adds that his wife “wouldn’t need to be forced” because she would “risk her life for her childrens. As any good mom would do.”

Read on……

Read more

What a stillbirth is

A stillbirth is the death of a fetus at or after 20 weeks of pregnancy. In the United States it occurs in about 1 in 170 pregnancies, roughly 21,000 cases per year. Most happen in the third trimester, particularly after 32 weeks.

Stillbirth is not a single disease. It is the final outcome of different processes.

The most common is placental failure, where the placenta no longer delivers enough oxygen and nutrients.

Other causes include fetal growth restriction, maternal medical illness, infection, and acute cord events. Importantly, many stillbirths are preceded by warning signs or identifiable risk factors. Prevention in obstetrics therefore means risk reduction and earlier intervention, not the unrealistic promise of zero risk. Stillbirths can still happen despite everything being done correctly.

1. Recognizing decreased fetal movement

The most frequent warning sign before many stillbirths is a change in fetal movement. In multiple studies, a large proportion of mothers who experienced stillbirth noticed their baby moving less in the days beforehand.

Beginning at about 28 weeks, a patient should know her baby’s usual pattern of activity. A sudden quiet pattern, weaker movement, or prolonged time to feel movement should prompt immediate evaluation. A practical method is to lie on the side and confirm that 10 movements are felt within two hours. Failure to reach that, or a clear deviation from the baby’s normal behavior, warrants calling labor and delivery the same day. Decreased movement is a physiologic symptom of fetal hypoxia, not maternal anxiety, and evaluation is simple and safe.

2. Detecting fetal growth restriction

A fetus that is not growing properly is at substantially higher risk of stillbirth, often because of placental insufficiency. The baby may appear normal but is receiving inadequate oxygen.

Routine prenatal care addresses this by measuring fundal height and performing ultrasound when growth is uncertain. When restriction is suspected, Doppler studies and surveillance are used. Detecting growth restriction often changes management and may lead to earlier delivery. This is one of the clearest examples in obstetrics where monitoring directly prevents fetal death.

3. Controlling maternal medical conditions

Maternal disease significantly affects placental function. Diabetes, hypertension, preeclampsia, thyroid disease, and autoimmune conditions all increase stillbirth risk through placental vascular injury.

Careful medical control lowers that risk. Good glucose control in diabetes, treatment of hypertension, and aspirin prophylaxis in high-risk pregnancies reduce placental complications. Prenatal care is therefore not only observation. It is active physiologic management aimed at protecting placental circulation.

4. Avoiding smoking and nicotine exposure

Smoking approximately doubles the risk of stillbirth. Carbon monoxide reduces fetal oxygen delivery and nicotine constricts placental blood vessels. The effect is dose related and biologically consistent.

The important point is that this applies not only to cigarettes but also to vaping and other nicotine products. Stopping smoking during pregnancy measurably reduces risk even if cessation occurs after the first trimester. Among modifiable factors in pregnancy, this is one of the most powerful.

5. Appropriate timing of delivery near term

The placenta ages. After 39 weeks its function gradually declines in some pregnancies. Stillbirth risk rises as pregnancy continues beyond term, particularly after 41 weeks.

Monitoring in late pregnancy and delivery at appropriate gestational ages reduce fetal death without increasing neonatal harm in properly selected pregnancies. Timing of delivery is therefore a biologic decision about placental function, not a matter of convenience.

6. Maternal sleep position in late pregnancy

Research from several countries shows that falling asleep on the back in the third trimester is associated with increased stillbirth risk. The likely mechanism is compression of major maternal blood vessels, reducing uterine blood flow.

The recommendation is simple and low burden. After about 28 weeks, begin sleep on the side. If a woman wakes on her back, she should simply turn back to the side. No intervention is needed beyond repositioning.

A realistic closing perspective

Not every stillbirth can be prevented. Congenital anomalies, sudden placental abruption, and acute cord accidents still occur even with excellent care. However, evidence consistently shows that many stillbirths are preceded by reduced movement, placental dysfunction, maternal disease, or modifiable exposures.

Stillbirth prevention is therefore based on vigilance, communication, and timely medical action. The purpose of prenatal care is early recognition of fetal compromise while intervention is still possible.

A clear, evidence-based way to monitor fetal movement in the third trimester

Advice about fetal movement is often imprecise. Patients are told to “be aware of movement,” but awareness alone is not a reliable clinical instruction. There is a simple, studied method that can be explained clearly and used at home.

Beginning at 28 weeks, the patient should pick a time of day when the baby is usually active, commonly in the evening or after eating. She should lie on her side, minimize distractions, and focus only on distinct movements such as kicks, rolls, or stretches. Hiccups are not counted.

She then counts how long it takes to feel 10 movements. In most healthy pregnancies, ten movements occur within about 30 minutes and almost always within two hours. The exact speed is less important than the baby’s usual pattern.

The key instruction is this. The patient should call Labor and Delivery immediately if ten movements are not felt within two hours, or if the baby’s activity is clearly weaker or quieter than its normal behavior, even if some movement is present. A sudden change matters more than an absolute number.

The biological reason is well understood. In placental insufficiency, the fetus becomes relatively hypoxic. To conserve oxygen, activity decreases. Reduced movement frequently precedes abnormal fetal heart rate testing and, in some cases, fetal death.

Observational and interventional studies show that structured fetal movement monitoring leads to earlier clinical evaluation. Most evaluations provide reassurance. A smaller number identify compromised fetuses and lead to timely delivery. The intervention itself is safe and noninvasive, and professional guidance supports responding promptly to reported decreased movement.

Clinically, decreased movement should be treated as a symptom, not as maternal anxiety.

Graph A — Reassuring pattern (normal variability 30–60 min)

How to interpret:
Day-to-day fluctuation is normal. The time to reach 10 movements changes, but it consistently stays within a healthy physiologic range. This is what we typically see when placental oxygen delivery is adequate.

Graph B — Concerning trend (progressively slower movements)

How to interpret:
The baby is still moving, but each day it takes longer to feel 10 movements. This is clinically important. A progressive increase in time to reach 10 movements can reflect developing placental insufficiency. Many stillbirths are preceded by exactly this pattern rather than a sudden complete absence of movement.

Key counseling message for patients

A single slow day may not mean danger.
A trend toward slower movement over several days is a symptom and should trigger evaluation.

How your partner can help

Stillbirth prevention is not only a medical issue. It is also an observation issue. The partner is often the first person to notice behavioral changes in the pregnancy.

A partner can help by learning the baby’s usual movement pattern together with the mother, especially in the evening when activity is easiest to feel. Sitting quietly together for a few minutes and asking, “Is the baby moving like usual today?” is not trivial reassurance. It is a form of monitoring. If the mother is unsure, the partner should encourage lying on the side and focusing on movements, not dismiss the concern.

Partners also play an important safety role in decision making. Many mothers hesitate to call the hospital because they worry about bothering staff or being told everything is fine. A partner should actively support contacting labor and delivery the same day if movement seems decreased or clearly different. Prompt evaluation is appropriate care, not overreaction.

Finally, partners can help by supporting medical recommendations that protect the placenta, including smoking cessation, keeping appointments, and attending visits when possible so that warning signs and instructions are understood by both parents. In several studies of delayed presentation after decreased fetal movement, hesitation and reassurance at home contributed to late evaluation. The practical message is simple. When in doubt, the partner should help escalate concern, not minimize it.

References

Stacey T, Thompson JMD, Mitchell EA, Ekeroma AJ, Zuccollo JM, McCowan LME. Maternal perception of fetal activity and late stillbirth risk. BMJ. 2011;342:d340. doi:10.1136/bmj.d340. PMID: 21273389.
Winje BA, Saastad E, Gunnes N, et al. Fetal movement counting and stillbirth prevention. BJOG. 2016;123:2079-2087. doi:10.1111/1471-0528.13818. PMID: 26846771.
ACOG Committee Opinion No. 828. Indications for outpatient antenatal fetal surveillance. Obstet Gynecol. 2021;137:e177-e197. doi:10.1097/AOG.0000000000004407. PMID: 33831926.

A pregnant woman wrote on Reddit that she repeatedly warned her clinicians about a prior shoulder dystocia and her fear that it could happen again. She felt reassured quickly, but not truly heard, and no detailed discussion followed. Labor proceeded without a clear plan that acknowledged her history. Shoulder dystocia then occurred again during delivery. What comes through most clearly is not rage, but the pain of having raised a medically relevant concern and feeling dismissed before a preventable crisis unfolded.

Listening Is a Professional Obligation

Listening to patients is not an optional courtesy or a communication style preference. It is a core element of professional responsibility. Patients often bring forward crucial information that lives outside protocols and checklists, including prior complications, bodily awareness, and lived experience. When a patient raises a specific concern rooted in past harm, the clinician’s duty is to pause, reassess risk, and engage seriously. Failure to do so is not benign reassurance. It is a clinical decision that carries ethical and safety consequences.

Read more

From a Reddit post:

What Is Freebirth?

Freebirth, also called unassisted birth, means deliberately giving birth without a midwife, nurse, or doctor present. It is not the same as home birth. In a planned home birth, a licensed midwife or nurse-midwife attends the delivery and brings emergency equipment. In a freebirth, no trained medical professional is there at all.

Read more……..

Read more

This is an r/pregnant Reddit post. A first-time mother at 40 weeks + 4 days with an uneventful pregnancy seeks advice before her scheduled induction. Despite a healthy pregnancy, she remains only 1cm dilated with no option for membrane sweeping. Her OB scheduled a Sunday night induction starting with cytotec (misoprostol), anticipating approximately 24 hours of labor. While expressing disappointment about not experiencing spontaneous labor, she maintains a positive outlook and asks the community for practical tips and things they wish they had known before their own inductions.

Comment Summary (78 comments)

The thread generated an overwhelmingly supportive response with practical advice spanning preparation, pain management, epidural timing, and emotional readiness. Comments ranged from brief encouragement to detailed birth narratives, with a notable emphasis on countering negative induction narratives with positive experiences.

Preparation Advice (25+ comments) The most consistent recommendation across comments was prioritizing rest before admission. Multiple commenters emphasized that induction can span 24-48+ hours, making pre-admission sleep critical. One commenter noted going from Friday evening to Sunday morning without real sleep. Practical packing suggestions included entertainment (books, streaming devices, word puzzles), personal comfort items (own pillows, robes, slippers, toiletries), and snacks for both during and after labor. Several noted hospital food inadequacy and recommended protein bars and jerky for sustained energy.

Food timing received significant attention. Multiple commenters advised eating a substantial meal before admission since many hospitals restrict patients to clear liquids once active labor begins, particularly after epidural placement. One commenter specifically noted being placed on a broth-only diet after her epidural.

Epidural Timing Debate (20+ comments) The thread revealed substantial disagreement about optimal epidural timing, reflecting genuine medical uncertainty. Several commenters shared experiences of resisting epidurals for 20+ hours based on fears of labor stalling, only to find the epidural actually accelerated dilation. One reported progressing from 5cm to 10cm after epidural placement. Another went from 3cm to 9cm in 2 hours post-epidural. A midwife in the thread explained that epidural-induced relaxation can help tense patients progress faster.

Conversely, one commenter explicitly stated she got her epidural too early and it prolonged everything by 18 hours, advising others to wait until further dilated if possible.

The more consistent advice: if you plan to get an epidural, request it before intense contractions make positioning difficult. Multiple commenters described struggling to hold still during epidural placement due to severe pain. One specifically warned that with pitocin inductions, contractions arrive suddenly and intensely, making the anesthesiologist wait time (sometimes 90+ minutes) excruciating.

Pitocin Pain Reality (15+ comments) A recurring theme was that pitocin-induced contractions differ qualitatively from spontaneous labor contractions. One midwife explained the physiological reason: natural oxytocin crosses the blood-brain barrier, triggering endorphin release for natural pain relief. Synthetic pitocin does not cross this barrier, resulting in more intense pain without compensatory endorphin response.

Multiple commenters described pitocin contractions as arriving like a “freight train” without the gradual buildup of natural labor. One commenter made it to 6cm before epidural but wished she’d gotten it sooner. Another described the worst pain of her life during the 90-minute wait for anesthesiology after requesting epidural.

Positive Induction Narratives (20+ comments) A notable feature of this thread was explicit pushback against negative induction narratives. One L&D nurse who had two elective 39-week inductions stated both were “perfect” and she’d choose induction again for a third pregnancy. Another commenter reported going from 2cm to 10cm in under 2 hours and pushing for 15 minutes. Multiple commenters described total labor times under 6 hours.

Several specifically noted that induction allowed them to plan, prepare the home, pack appropriately, and arrive rested. One pointed out the psychological benefit of knowing exactly when labor would begin rather than experiencing unpredictable onset.

A friend’s story was shared of progressing from 1cm to 9cm in one hour as a first-time mother, with nurses shocked when a practice push revealed the baby’s head immediately visible.

Variable Duration Reports Labor durations reported in comments ranged dramatically: 2 hours, 4 hours, 6 hours, 10 hours, 15 hours, 17 hours, 26 hours, 44 hours, and 4 days (using sequential methods). Starting dilation appeared to influence duration, with several noting that arriving at 4cm resulted in much faster progression. One commenter at 1cm dilated had a 6-hour intense labor, while another at 1cm reported 44 hours.

Induction Methods Discussed Comments referenced multiple ripening and induction agents: cytotec/misoprostol (oral or buccal), cervical pessaries, Foley balloon catheters, cervidil, and pitocin. Several women required multiple rounds of cervical ripening before active labor. One commenter had 3 rounds of cytotec (12 hours total) before pitocin even started. Another was induced for 4 days across three methods. The Foley balloon generated some discussion, with an L&D nurse clarifying that most women tolerate it without epidural, contrary to one commenter’s suggestion to request epidural before balloon placement.

Mobility and Positioning (8+ comments) Several commenters emphasized staying mobile and upright as long as possible. Recommendations included using birth balls, walking, and rotating positions. The peanut ball received specific mention as helpful for women confined to bed with epidurals. One commenter suggested asking about wireless monitoring to allow movement while maintaining fetal surveillance.

Unexpected Outcomes (5+ comments) A few commenters shared that their bodies went into spontaneous labor before scheduled inductions, sometimes on the induction date itself. One woman noted both her scheduled inductions resulted in spontaneous labor starting on the appointment day. Another went from scheduled induction to active labor over the weekend before her appointment.

Several mentioned that induction doesn’t guarantee vaginal delivery. One labored 17 hours before cesarean due to baby’s position and inability to establish contraction patterns. The thread maintained a realistic but non-alarmist tone about this possibility.

Analysis

This thread represents peer support functioning as intended, with experienced mothers sharing practical wisdom that healthcare systems often fail to provide. The collective knowledge addresses gaps in standard prenatal education, where induction procedures may be explained medically but lived experience remains inaccessible.

Several professional accountability observations emerge:

Informed Consent Adequacy: The sheer volume of “I wish I’d known” comments suggests systematic gaps in pre-induction counseling. When dozens of women report surprise at pitocin pain intensity, epidural timing constraints, or multi-day induction possibilities, the informed consent process warrants examination. Patients scheduled for induction should receive explicit discussion of: realistic duration ranges (2-48+ hours), qualitative differences between induced and spontaneous contractions, epidural timing considerations and anesthesiology availability, food and activity restrictions, and cesarean possibility statistics for inductions at various starting conditions.

Pain Management Communication: The epidural timing debate reveals a communication failure. Patients arrive with conflicting information (epidurals stall labor vs. epidurals enable progress) and receive insufficient guidance for their specific clinical situation. The commenter who waited 90 minutes in severe pain for anesthesiology represents a systems failure, not personal miscalculation.

Expectation Setting: The original poster’s OB anticipated 24-hour labor. Thread responses suggest this estimate, while reasonable, may not prepare patients for the genuine possibility of 40+ hour inductions. Under-promising duration creates unnecessary anxiety when labor extends; realistic range communication respects patient autonomy.

Positive Observation: Unlike threads documenting traumatic care, this discussion reflects women feeling empowered to advocate for themselves within the medical system. Commenters describing epidural requests, snack smuggling, and entertainment preparation demonstrate patients actively managing their experience rather than passively receiving care.